Coronary artery disease and transcatheter aortic valve replacement: Current treatment paradigms

Coronary Artery Disease

Volumn 26, Issue 3, 2015, Pages 272-278

  Paradis, Jean Michel ^a,b   Labbé, Benoit ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

aortic stenosis; coronary artery disease; coronary revascularization; percutaneous coronary intervention; transcatheter aortic valve replacement

Indexed keywords

AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTERY CATHETERIZATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR SYMPTOM; CLINICAL EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY HEMODYNAMICS; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; PATIENT SELECTION; PROCEDURES; RISK FACTOR; TIME FACTOR;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928283240     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000210     Document Type: Review

References (60)

1. Rapp AH, Hillis LD, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol 2001; 87:1216-1217.
2. Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol 1988; 62:117-120.
3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630-634.
4. Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012; 60:169-180.
5. Iung B. Interface between valve disease and ischaemic heart disease. Heart 2000; 84:347-352.
6. Adler Y, Vaturi M, Herz I, Iakobishvili Z, Toaf J, Fink N, et al. Nonobstructive aortic valve calcification: a window to significant coronary artery disease. Atherosclerosis 2002; 161:193-197.
7. Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747-756.
8. Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol 1983; 51:1005-1028.
9. Thubrikar MJ, Deck JD, Aouad J, Chen JM. Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve. Atherosclerosis 1985; 55:299-311.
10. Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 1997; 95:892-898.
11. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57-e185.
12. Garcia D, Camici PG, Durand LG, Rajappan K, Gaillard E, Rimoldi OE, Pibarot P. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol (1985) 2009; 106:113-121.
13. Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, Camici PG. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002; 105:470-476.
14. Bartel T, Yang Y, Müller S, Wenzel RR, Baumgart D, Philipp T, Erbel R. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol 2002; 39:2012-2018.
15. Stefanini GG, Stortecky S, Meier B, Windecker S, Wenaweser P. Severe aortic stenosis and coronary artery disease. EuroIntervention 2013; 9 (Suppl):S63-S68.
16. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van't Veer M, et al. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213-224.
17. Stähli BE, Maier W, Corti R, Lüscher TF, Altwegg LA. Fractional flow reserve evaluation in patients considered for transfemoral transcatheter aortic valve implantation: a case series. Cardiology 2012; 123:234-239.
18. Demirkol MO, Yaymaci B, Debe H, Baaran Y, Turan F. Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis. Cardiology 2002; 97:37-42.
19. Aranki SF, Rizzo RJ, Couper GS, Adams DH, Collins JJ Jr, Gildea JS, et al. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation 1993; 88 (5 Pt 2):II17-II23.
20. Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010; 89:758-767. Discussion 767.
21. Tjang YS, van Hees Y, Körfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur J Cardiothorac Surg 2007; 32:469-474.
22. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007; 83:921-929.
23. Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 2013; 61:837-848.
24. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation 2012; 125:1005-1013.
25. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231-1243.
26. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597-1607.
27. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-2198.
28. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366:1705-1715.
29. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. German Transcatheter Aortic Valve Interventions-Registry Investigators. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol 2013; 112:272-279.
30. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124:425-433.
31. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011; 58:2130-2138.
32. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123:299-308.
33. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4:242-249.
34. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55:1080-1090.
35. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol 2011; 58:2151-2162.
36. Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schächinger V, et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans- A pical aortic-valve implantation. Eur J Cardiothorac Surg 2011; 39:532-537.
37. Petronio AS, De Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, et al. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access. J Am Coll Cardiol 2012; 60:502-507.
38. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008; 1:167-175.
39. Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, et al. PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32:148-157.
40. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Détaint D, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009; 54:303-311.
41. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008; 86:46-54. Discussion 54-55.
42. Khawaja MZ, Asrress KN, Haran H, Arri S, Nadra I, Bolter K, et al. The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 2014; pii:20131105-04.
43. Stefanini GG, Stortecky S, Cao D, Rat-Wirtzler J, O'Sullivan CJ, Gloekler S, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J 2014; 35:2530-2540.
44. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381:629-638.
45. Masson JB, Lee M, Boone RH, Al Ali A, Al Bugami S, Hamburger J, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76:165-173.
46. D'Ascenzo F, Conrotto F, Giordana F, Moretti C, D'Amico M, Salizzoni S, et al. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta- A nalysis of adjusted observational results. Int J Cardiol 2013; 168:2528-2532.
47. Gautier M, Pepin M, Himbert D, Ducrocq G, Iung B, Dilly MP, et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 2011; 7:549-555.
48. Van Mieghem NM, van der Boon RM, Faqiri E, Diletti R, Schultz C, van Geuns RJ, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv 2013; 6:867-875.
49. Ussia GP, Barbanti M, Colombo A, Tarantini G, Petronio AS, Ettori F, et al. CoreValve Italian Registry Investigators. Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry. Int J Cardiol 2013; 167:943-950.
50. Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011; 57:1988-1999.
51. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451-2496.
52. Gasparetto V, Fraccaro C, Tarantini G, Buja P, D'Onofrio A, Yzeiraj E, et al. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013; 81:376-383.
53. Wendt D, Kahlert P, Lenze T, Neuhaüser M, Price V, Konorza T, et al. Management of high-risk patients with aortic stenosis and coronary artery disease. Ann Thorac Surg 2013; 95:599-605.
54. Abdel-Wahab M, Mostafa AE, Geist V, Stöcker B, Gordian K, Merten C, et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol 2012; 109:581-586.
55. Wenaweser P, Pilgrim T, Guerios E, Stortecky S, Huber C, Khattab AA, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011; 7:541-548.
56. Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011; 100:311-316.
57. Pasic M, Dreysse S, Unbehaun A, Buz S, Drews T, Klein C, et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012; 14:463-468.
58. Geist V, Sherif MA, Khattab AA. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. Catheter Cardiovasc Interv 2009; 73:61-67.
59. Zajarias A, Eltchaninoff H, Cribier A. Successful coronary intervention after percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2007; 69:522-524.
60. Stortecky S, Buellesfeld L, Wenaweser P, Heg D, Pilgrim T, Khattab AA, et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013; 6:77-84.